Combined prostate diffusion tensor imaging and dynamic contrast enhanced MRI at 3T--quantitative correlation with biopsy.
The purpose of this work was to compare diagnostic accuracy of Diffusion Tensor Imaging (DTI), dynamic contrast-enhanced magnetic resonance imaging (DCE MRI) and their combination in diagnosing prostate cancer. Twenty-five patients with clinical suspicion of prostate cancer underwent MRI, prior to transrectal ultrasound-guided biopsies. MRI data were correlated to biopsy results. Logistic regression models were constructed for the DTI parameters, DCE MRI parameters, and their combination. The areas under the receiver operator characteristic curves (AUC) were compared between the models. The nonparametric Wilcoxon signed rank test was used for statistical analysis. The sensitivity and specificity values were respectively 81% (74-87%) and 85% (79-90%) for DTI and 63% (55-70%) and 90% (85-94%) for DCE. The combination "DTI or DCE MRI" had 100% (97-100%) sensitivity and 77% (69-83%) specificity, while "DTI and DCE MRI" had 44% (37-52%) sensitivity and 98% (94-100%) specificity. The AUC for DTI+DCE parameters was significantly higher than that for either DTI (0.96 vs. 0.92, P=.0143) or DCE MRI parameters (0.96 vs. 0.87, P=.00187) alone. In conclusion, the combination of DTI and DCE MRI has significantly better accuracy in prostate cancer diagnosis than either technique alone.
Kozlowski
Piotr
P
The Prostate Centre at Vancouver General Hospital, Vancouver, BC, Canada. pkozlow@interchange.ubc.ca
Chang
Silvia D
SD
Meng
Ran
R
Mädler
Burkhard
B
Bell
Robert
R
Jones
Edward C
EC
Goldenberg
S Larry
SL
D000328:Adult; D000368:Aged; D001706:Biopsy; D003287:Contrast Media; D038524:Diffusion Magnetic Resonance Imaging / Q000379:methods*; D017352:Echo-Planar Imaging / Q000379:methods*; D019786:Gadolinium DTPA; D006801:Humans; D008297:Male; D008875:Middle Aged; D011471:Prostatic Neoplasms / Q000473:pathology*; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity; D013223:Statistics as Topic
D003287:Contrast Media; D019786:Gadolinium DTPA
Acta Radiol. 2008 Jun;49(5):602-10
18568549
Int J Radiat Oncol Biol Phys. 2009 Jun 1;74(2):399-403
19019564
Stat Med. 1998 Apr 30;17(8):857-72
9595616
Radiology. 2004 Dec;233(3):709-15
15498903
J Magn Reson Imaging. 2004 Oct;20(4):654-61
15390142
Acta Radiol. 2008 Dec;49(10):1207-13
19031184
AJR Am J Roentgenol. 2007 Aug;189(2):323-8
17646457
Invest Radiol. 2006 Feb;41(2):185-8
16428991
Clin Radiol. 2000 Feb;55(2):99-109
10657154
J Magn Reson Imaging. 2006 Jul;24(1):108-13
16767709
Magn Reson Imaging. 2007 Dec;25(10):1423-9
17499468
J Magn Reson Imaging. 2009 Aug;30(2):327-34
19629981
Radiology. 2003 Oct;229(1):248-54
12944607
Radiology. 1996 Mar;198(3):795-805
8628874
AJR Am J Roentgenol. 2007 Jan;188(1):91-8
17179350
Magn Reson Imaging. 2008 Oct;26(8):1071-80
18508221
Urology. 1996 Oct;48(4):594-9
8886066
Magn Reson Med. 2009 Apr;61(4):842-50
19215051
Eur J Radiol. 2010 Feb;73(2):352-6
19084363
J Magn Reson Imaging. 2008 Jun;27(6):1331-5
18504751
Magn Reson Med. 2004 Sep;52(3):530-7
15334571
Eur Radiol. 2008 Apr;18(4):716-21
17960389
Magn Reson Med. 2006 Nov;56(5):993-1000
17036301
Invest Radiol. 2007 Jun;42(6):412-9
17507813
Magn Reson Med. 2000 Jun;43(6):828-36
10861877
Biometrics. 1988 Sep;44(3):837-45
3203132
J Magn Reson Imaging. 1997 May-Jun;7(3):564-74
9170043
Invest Radiol. 2009 Sep;44(9):572-6
19692841
Eur Radiol. 2009 Mar;19(3):770-8
18925403
J Magn Reson Imaging. 1999 Sep;10(3):223-32
10508281